StockData
BriaCell Therapeutics Corp. logo

BriaCell Therapeutics Corp. (BCTX) income statement

BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 4/30
$3.51+0.21 (+6.36%)

Close on Nov 17, 2026Market cap $30.65MP/E –Yield –

BriaCell Therapeutics Corp. income statement

Ratios

Latest available, balances at Jul 31, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2026
–

Financial strength

Current ratio
2.76
Debt to equity
–
Debt to assets
–
Cash to current liabilities
123.4%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?